Business
A Southwest pilot gives a thumbs up
(Albany Times Union/Getty Images)
Check it

Starting Wednesday, bags fly for $35 at Southwest

Last September, Southwest said introducing a bag fee would help it earn up to $1.5 billion in additional annual revenue.

Max Knoblauch

The more than five-decade-long “bags fly free” policy at Southwest Airlines is ending Wednesday, and the company just about waited until the boarding doors were closing to provide some details.

As of tomorrow, customers will pay $35 for their first checked bag and $45 for the second, The Wall Street Journal reports. That puts Southwest in line with its big four rivals.

Exceptions to the new charge include passengers at the top of Southwest’s loyalty program and passengers buying the highest fare type, who will still be able to fly two bags for free. Credit card holders will get one bag, similar to the policy at Delta Air Lines.

Southwest moved quickly to institute the unpopular baggage fee, which was first announced in March. In comparison, the carrier’s shift to assigned seating, which was announced in July 2024, won’t go into effect until the first quarter of 2026. The reason for the hurry? Cold hard cash.

Last September, Southwest said that charging for bags would bring in up to $1.5 billion in additional annual revenue. At the time, the airline also said the move wouldn’t be financially smart as it would result in an estimated $1.8 billion in lost market share.

According to Southwest, its free bags policy was “the most important feature by far in setting Southwest apart from other airlines” and changing it “would drive down demand and far outweigh any revenue gains.”

At the time, the company said: “In each scenario we tested or they tested, changing our bags policy would be value destructive. The results show too much defection in future flying, even in markets where we're strong, that more than offset the ancillary revenue we'd earn from bag fees. ...And as you can see, the loss in trips flown from customer defection overwhelms the value of the incremental ancillary revenue from bag fees and results in $300 million less in revenue."

Of course, all that was a few months before the company ceded five board seats to activist investor Elliott Management in October and began its recent cost-cutting tear.

More Business

See all Business
business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.